Extended Data Fig. 2: Patient characteristics.
From: Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
Indicated variables shown for the three patients enrolled on dose level 1. INSS: International Neuroblastoma Staging System; **Cy: cyclophosphamide, Flu: fludarabine. $: Dose: CAR-NKT cells / m2. Response criteria determined by revised International Neuroblastoma Response Criteria; partial response = elimination of at least 50% of bone metastatic lesions. DOD: Died of disease. AWD: Alive with disease.
